Standout Papers

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer 2018 2026 2020 2023 658
  1. Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer (2018)
    Maha Hussain, Karim Fizazi et al. New England Journal of Medicine

Immediate Impact

58 standout
Sub-graph 1 of 18

Citing Papers

Prostate Cancer
2025 Standout
Transcription regulation by long non-coding RNAs: mechanisms and disease relevance
2024 Standout
11 intermediate papers

Works of Per Rathenborg being referenced

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
2018 Standout
Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC).
2013
and 5 more

Author Peers

Author Last Decade Papers Cites
Per Rathenborg 892 317 300 18 1.1k
Joanna Vergidis 746 370 198 27 949
Daygen L. Finch 856 429 191 36 1.2k
George Armitage 987 269 220 14 1.4k
Robert J. van Soest 774 346 258 25 913
Vahid Naini 1028 337 401 20 1.1k
Maria De Santis 1225 249 464 24 1.4k
Zafeiris Zafeiriou 528 340 172 31 856
Chris Wynne 1009 182 312 28 1.3k
Mari Nakazawa 824 425 187 23 993
Eren Demirhan 657 224 211 15 924

All Works

Loading papers...

Rankless by CCL
2026